Glaxosmithkline - Latest News  

Squalene - an additive proposed for possible use in swine flu vaccine - causes incurable diseases in animals.

Amy M. Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, to give Keynote Presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit on October 14-16, 2009 in San Diego,CA

Greater Philadelphia Region Healthcare Nonprofits to Receive Up to $400,000 in Funding – Application Deadline July 15, 2009

The HIV Pill, HIV Abzymes, GML Gel and GML Cream are new weapons that can kill the HIV virus.

Greater Philadelphia Region Nonprofits Receive the GlaxoSmithKline 12th Annual IMPACT Awards

Qualified Nonprofit Winners to Receive $40,000 Each – Application Deadline is July 10, 2008. Applications for outstanding achievement and excellence in providing healthcare access will be accepted through 4 p.m., EDT on July 10, 2008.

(Bucks County Nonprofit Receives the GlaxoSmithKline 11th Annual IMPACT Awards)

GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, has announced the recipients of the GlaxoSmithKline 11th Annual IMPACT Awards.

Homes in Motion's Ann Jagger, as the co-founder and co-owner of a company that helps homeowners enhance their homes for a more profitable sale, recently shared real-world finance with N.C. Girl Scouts at the annual Techno Quest event in Raleigh.

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds the HIV market, forecast to be worth $11.5 billion in 2016, is set to undergo significant changes.

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which forecasts that there is likely to be a $40.1 billion growth in the pharmaceutical market in 11 countries in Western Europe.